Business Description
Zentalis Pharmaceuticals is a San Diego-based drug development company founded in 2014, working to bring new cancer treatments to patients across the United States. Its primary focus is azenosertib, a compound currently being tested in multiple clinical trials targeting ovarian cancer, other solid tumors, and cases where patients have stopped responding to existing therapies. The company also works alongside licensing and research partners to advance its pipeline.
